Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
CNY 3.4
(-0.58%)
CNY 3.4
(-0.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | -10.23% |
| 2022 | 1.21 Billion CNY | -10.02% |
| 2021 | 1.35 Billion CNY | 8.02% |
| 2020 | 1.25 Billion CNY | -14.51% |
| 2019 | 1.46 Billion CNY | 2.16% |
| 2018 | 1.43 Billion CNY | 14.08% |
| 2017 | 1.25 Billion CNY | 13.39% |
| 2016 | 1.1 Billion CNY | 28.69% |
| 2015 | 861.13 Million CNY | 34.9% |
| 2014 | 638.33 Million CNY | 79.53% |
| 2013 | 355.55 Million CNY | 26.72% |
| 2012 | 280.58 Million CNY | 20.34% |
| 2011 | 233.15 Million CNY | 12.42% |
| 2010 | 207.4 Million CNY | -11.09% |
| 2009 | 233.28 Million CNY | 23.2% |
| 2008 | 189.35 Million CNY | 34.18% |
| 2007 | 141.11 Million CNY | 25.34% |
| 2006 | 112.59 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 270.15 Million CNY | 0.69% |
| 2024 Q3 | 288.63 Million CNY | 6.84% |
| 2024 Q1 | 268.31 Million CNY | 13.87% |
| 2023 Q2 | 343.95 Million CNY | 18.22% |
| 2023 Q3 | 327.74 Million CNY | -4.71% |
| 2023 FY | 1.09 Billion CNY | -10.23% |
| 2023 Q4 | 235.62 Million CNY | -28.11% |
| 2023 Q1 | 290.94 Million CNY | 7.86% |
| 2022 Q1 | 306.32 Million CNY | -15.13% |
| 2022 FY | 1.21 Billion CNY | -10.02% |
| 2022 Q4 | 269.75 Million CNY | -14.51% |
| 2022 Q3 | 315.51 Million CNY | -3.03% |
| 2022 Q2 | 325.36 Million CNY | 6.21% |
| 2021 Q1 | 307.77 Million CNY | -12.0% |
| 2021 Q3 | 353.39 Million CNY | 6.97% |
| 2021 Q4 | 360.94 Million CNY | 2.14% |
| 2021 FY | 1.35 Billion CNY | 8.02% |
| 2021 Q2 | 330.37 Million CNY | 7.34% |
| 2020 Q1 | 196.59 Million CNY | -49.7% |
| 2020 Q4 | 349.73 Million CNY | -6.78% |
| 2020 FY | 1.25 Billion CNY | -14.51% |
| 2020 Q3 | 375.18 Million CNY | 13.5% |
| 2020 Q2 | 330.56 Million CNY | 68.14% |
| 2019 Q1 | 303.91 Million CNY | -12.84% |
| 2019 Q4 | 390.81 Million CNY | 0.93% |
| 2019 Q2 | 382.56 Million CNY | 25.88% |
| 2019 Q3 | 387.21 Million CNY | 1.21% |
| 2019 FY | 1.46 Billion CNY | 2.16% |
| 2018 Q4 | 348.68 Million CNY | 5.61% |
| 2018 Q3 | 330.16 Million CNY | -22.29% |
| 2018 Q2 | 424.87 Million CNY | 28.83% |
| 2018 FY | 1.43 Billion CNY | 14.08% |
| 2018 Q1 | 329.8 Million CNY | 3.23% |
| 2017 Q3 | 379.03 Million CNY | 22.09% |
| 2017 Q2 | 310.44 Million CNY | 25.36% |
| 2017 FY | 1.25 Billion CNY | 13.39% |
| 2017 Q1 | 247.64 Million CNY | -23.5% |
| 2017 Q4 | 319.48 Million CNY | -15.71% |
| 2016 FY | 1.1 Billion CNY | 28.69% |
| 2016 Q2 | 281.86 Million CNY | 30.09% |
| 2016 Q3 | 285.96 Million CNY | 1.46% |
| 2016 Q4 | 323.7 Million CNY | 13.2% |
| 2016 Q1 | 216.66 Million CNY | -19.38% |
| 2015 FY | 861.13 Million CNY | 34.9% |
| 2015 Q2 | 217.36 Million CNY | 39.26% |
| 2015 Q1 | 156.08 Million CNY | -27.28% |
| 2015 Q4 | 268.73 Million CNY | 22.74% |
| 2015 Q3 | 218.95 Million CNY | 0.73% |
| 2014 Q2 | 176.07 Million CNY | 165.32% |
| 2014 Q1 | 66.36 Million CNY | -40.18% |
| 2014 Q3 | 181.24 Million CNY | 2.93% |
| 2014 FY | 638.33 Million CNY | 79.53% |
| 2014 Q4 | 214.64 Million CNY | 18.43% |
| 2013 Q1 | 67.45 Million CNY | -18.68% |
| 2013 Q2 | 81.19 Million CNY | 20.37% |
| 2013 Q3 | 95.96 Million CNY | 18.19% |
| 2013 Q4 | 110.93 Million CNY | 15.6% |
| 2013 FY | 355.55 Million CNY | 26.72% |
| 2012 FY | 280.58 Million CNY | 20.34% |
| 2012 Q1 | 54.61 Million CNY | -25.35% |
| 2012 Q2 | 68.82 Million CNY | 26.01% |
| 2012 Q3 | 74.19 Million CNY | 7.8% |
| 2012 Q4 | 82.95 Million CNY | 11.81% |
| 2011 Q3 | 54.74 Million CNY | -10.77% |
| 2011 Q2 | 61.35 Million CNY | 39.78% |
| 2011 Q1 | 43.89 Million CNY | -19.57% |
| 2011 FY | 233.15 Million CNY | 12.42% |
| 2011 Q4 | 73.16 Million CNY | 33.63% |
| 2010 Q1 | 46.51 Million CNY | -37.54% |
| 2010 Q2 | 60.24 Million CNY | 29.53% |
| 2010 FY | 207.4 Million CNY | -11.09% |
| 2010 Q4 | 54.57 Million CNY | 18.47% |
| 2010 Q3 | 46.06 Million CNY | -23.54% |
| 2009 FY | 233.28 Million CNY | 23.2% |
| 2009 Q1 | 45.83 Million CNY | 0.0% |
| 2009 Q2 | 57.76 Million CNY | 26.02% |
| 2009 Q4 | 74.46 Million CNY | 33.23% |
| 2009 Q3 | 55.89 Million CNY | -3.24% |
| 2008 FY | 189.35 Million CNY | 34.18% |
| 2007 FY | 141.11 Million CNY | 25.34% |
| 2006 FY | 112.59 Million CNY | 0.0% |